# RIFAPENTINE
> **ANDA217042** · Abbreviated New Drug Application (Generic) · Sponsor: MACLEODS PHARMS · Approved 2026-06-23
## Drug
- **FDA Application Number:** ANDA217042
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** RIFAPENTINE
- **Generic name:** RIFAPENTINE
- **Active ingredients:** RIFAPENTINE
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** MACLEODS PHARMS
- **Manufacturer:** Macleods Pharmaceuticals Limited
- **First approval:** 2026-06-23
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=217042)
---
*MORVS · CC0 1.0*